FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310715033> ?p ?o ?g. }

• W4310715033 endingPage "4177" @default.
• W4310715033 startingPage "4161" @default.
• W4310715033 abstract "To investigate the effect of canagliflozin (20 mg/kg) on hepatic steatosis and atherosclerosis, and further to explore its possible mechanism.Blood glucose, blood lipid, oxidative stress response and inflammatory cytokines were examined by intraperitoneal glucose tolerance test and ELISA assay. HE and Oil Red O staining were used to estimate the extent of hepatic steatosis and atherosclerosis. RNA-seq and qRT-PCR were used to further investigate the potential mechanism. The effects of canagliflozin on autophagy were detected using transmission electron microscopy and Western blotting. The endothelial function-related markers were determined by qRT-PCR.Canagliflozin notably alleviated the elevation in blood glucose and insulin resistance in western diet-fed ApoE-/- mice. In ApoE-/-+Cana group, ApoE-/- mice had lower levels of TG, TC, LDL-C, TNF-α, IL-6, IL-1β, and MCP-1. HE and Oil Red O staining presented that canagliflozin restrained the atherosclerotic plaque development and lipid accumulation. RNA-seq showed that 87 DEGs were relevant to improvement of hepatic steatosis and atherosclerosis by canagliflozin. Among them, CPS1, ASS1, ASL, ARG1, MATLA, GLS2, GOT1, SREBP1, Plin5, Retreg1, and C/EBPβ were verified. KEGG enrichment analysis indicated that DEGs were mainly involved in amino acid metabolism. Besides, we observed that canagliflozin reduced the contents of aspartic acid and citrulline in liver. Western blotting showed that ASS1 and p-AMPK/AMPK was remarkably elevated after administration of canagliflozin. Correspondingly, canagliflozin down-regulated SREBP1, FAS, ACC1, HMGCR, p-mTOR/m-TOR, p-ULK1/ULK1 and p62, but up-regulated CPT1, Beclin 1 and LC3 II/LC3I. TEM showed that canagliflozin reduced the number of lipid droplets and increased the autophagosomes. Moreover, we found that canagliflozin elevated the aortic endothelial function-associated markers including ASS1, ASL and eNOS.Canagliflozin may attenuate hepatic steatosis by improving lipid metabolism, enhancing autophagy, and reducing inflammatory response through ASS1/AMPK pathway. Besides, canagliflozin further effectively improves the aortic endothelial function, thereby suppressing atherosclerosis development." @default.
• W4310715033 created "2022-12-16" @default.
• W4310715033 creator A5003642180 @default.
• W4310715033 creator A5007410863 @default.
• W4310715033 creator A5008008825 @default.
• W4310715033 creator A5015042324 @default.
• W4310715033 creator A5036499113 @default.
• W4310715033 creator A5046452161 @default.
• W4310715033 creator A5058246242 @default.
• W4310715033 creator A5059603277 @default.
• W4310715033 creator A5062826296 @default.
• W4310715033 creator A5088142461 @default.
• W4310715033 date "2022-12-01" @default.
• W4310715033 modified "2023-10-17" @default.
• W4310715033 title "Canagliflozin Attenuates Hepatic Steatosis and Atherosclerosis Progression in Western Diet-Fed ApoE-Knockout Mice" @default.
• W4310715033 cites W1519974564 @default.
• W4310715033 cites W1523693806 @default.
• W4310715033 cites W1958022600 @default.
• W4310715033 cites W1970637701 @default.
• W4310715033 cites W1974864689 @default.
• W4310715033 cites W1983085727 @default.
• W4310715033 cites W1996067821 @default.
• W4310715033 cites W2003632211 @default.
• W4310715033 cites W2004092474 @default.
• W4310715033 cites W2011574523 @default.
• W4310715033 cites W2028320377 @default.
• W4310715033 cites W2039999119 @default.
• W4310715033 cites W2051512233 @default.
• W4310715033 cites W2057218469 @default.
• W4310715033 cites W2065612971 @default.
• W4310715033 cites W2068171948 @default.
• W4310715033 cites W2086453930 @default.
• W4310715033 cites W2091049385 @default.
• W4310715033 cites W2124481954 @default.
• W4310715033 cites W2133638738 @default.
• W4310715033 cites W2168436114 @default.
• W4310715033 cites W2172053085 @default.
• W4310715033 cites W2279717914 @default.
• W4310715033 cites W2289637790 @default.
• W4310715033 cites W2324274669 @default.
• W4310715033 cites W2324751250 @default.
• W4310715033 cites W2329234205 @default.
• W4310715033 cites W2411868630 @default.
• W4310715033 cites W2742731108 @default.
• W4310715033 cites W2788727968 @default.
• W4310715033 cites W2800603965 @default.
• W4310715033 cites W2884101530 @default.
• W4310715033 cites W2917128826 @default.
• W4310715033 cites W2953536521 @default.
• W4310715033 cites W2955807511 @default.
• W4310715033 cites W2969476079 @default.
• W4310715033 cites W2981265650 @default.
• W4310715033 cites W2989917244 @default.
• W4310715033 cites W2999435537 @default.
• W4310715033 cites W3000784408 @default.
• W4310715033 cites W3006947875 @default.
• W4310715033 cites W3034040592 @default.
• W4310715033 cites W3036630081 @default.
• W4310715033 cites W3042455526 @default.
• W4310715033 cites W3104353694 @default.
• W4310715033 cites W3135652267 @default.
• W4310715033 cites W3160177741 @default.
• W4310715033 cites W3169399514 @default.
• W4310715033 cites W3169474406 @default.
• W4310715033 doi "https://doi.org/10.2147/dddt.s388823" @default.
• W4310715033 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36510490" @default.
• W4310715033 hasPublicationYear "2022" @default.
• W4310715033 type Work @default.
• W4310715033 citedByCount "2" @default.
• W4310715033 countsByYear W43107150332023 @default.
• W4310715033 crossrefType "journal-article" @default.
• W4310715033 hasAuthorship W4310715033A5003642180 @default.
• W4310715033 hasAuthorship W4310715033A5007410863 @default.
• W4310715033 hasAuthorship W4310715033A5008008825 @default.
• W4310715033 hasAuthorship W4310715033A5015042324 @default.
• W4310715033 hasAuthorship W4310715033A5036499113 @default.
• W4310715033 hasAuthorship W4310715033A5046452161 @default.
• W4310715033 hasAuthorship W4310715033A5058246242 @default.
• W4310715033 hasAuthorship W4310715033A5059603277 @default.
• W4310715033 hasAuthorship W4310715033A5062826296 @default.
• W4310715033 hasAuthorship W4310715033A5088142461 @default.
• W4310715033 hasBestOaLocation W43107150331 @default.
• W4310715033 hasConcept C122927707 @default.
• W4310715033 hasConcept C126322002 @default.
• W4310715033 hasConcept C13028836 @default.
• W4310715033 hasConcept C134018914 @default.
• W4310715033 hasConcept C171089720 @default.
• W4310715033 hasConcept C184235292 @default.
• W4310715033 hasConcept C185592680 @default.
• W4310715033 hasConcept C2776175330 @default.
• W4310715033 hasConcept C2776954865 @default.
• W4310715033 hasConcept C2777180221 @default.
• W4310715033 hasConcept C2777391703 @default.
• W4310715033 hasConcept C2777451236 @default.
• W4310715033 hasConcept C2778163477 @default.
• W4310715033 hasConcept C2778435403 @default.
• W4310715033 hasConcept C2778772119 @default.
• W4310715033 hasConcept C2778913445 @default.

• next